𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The primary structure of a feline class I gene: Striking similarity toHLA-A

✍ Scribed by Martien van Hoof; Jan Peter de Geus; Marleen Roos; Caroline Brown; Heinz Jacobs; Hidde Ploegh


Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
420 KB
Volume
30
Category
Article
ISSN
0093-7711

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A feline class II Ξ± gene with striking s
✍ Adrie J. M. Verhoeven; Marleen H. Roost; Hidde L. Ploegh πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 543 KB

A genomic library was constructed from DNA of a domestic cat and screened with a human HLA-DR alpha probe at low stringency. Several positive clones were isolated, and the DNA sequence of one of these clones was determined. Comparison with class II alpha gene sequences from other species suggested t

Structure of a functional rabbit class I
✍ Patrice N. Marche; Mark L. Tykocinski; Edward E. Max; Thomas J. Kindt πŸ“‚ Article πŸ“… 1985 πŸ› Springer-Verlag 🌐 English βš– 1004 KB

Studies of rabbit major histocompatibility complex proteins have suggested that rabbits express only a single class I antigen, in contrast to most mouse strains (H-2K, D, and L) and man (HLA-A, -B, and -C), which express three. To explore the significance and the molecular basis of this apparent spe

The cataract Shionogi mouse, a sister st
✍ H. Ikegami; S. Makino; M. Harada; G. S. Eisenbarth; M. Hattori πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 509 KB

We have studied with a series of monoclonal antibodies and restriction fragment analysis the K, D, and class II region of the major histocompatibility complex of the non-obese diabetic mouse in comparison with its sister strains, the non-obese non-diabetic and cataract Shionogi mouse. (1) K region:

Neoadjuvant gene delivery of feline gran
✍ Cornelia HΓΌttinger; Johannes Hirschberger; Anika Jahnke; Roberto KΓΆstlin; Thomas πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 148 KB

## Abstract Despite aggressive pre‐ or postoperative treatment, feline fibrosarcomas have high recurrence rates. Immunostimulatory gene therapy is a promising approach in veterinary oncology. This phase I dose‐escalation study was performed to determine toxicity and feasibility of gene therapy with